BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen TL, Chen TG, Tai YT, Chang HC, Chen RM, Lin CJ, Ueng TH. Propofol inhibits renal cytochrome P450 activity and enflurane defluorination in vitro in hamsters. Can J Anaesth. 2000;47:680-686. [PMID: 10930209 DOI: 10.1007/bf03019002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Yang LQ, Yu WF, Cao YF, Gong B, Chang Q, Yang GS. Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes. World J Gastroenterol 2003; 9(9): 1959-1962 [PMID: 12970884 DOI: 10.3748/wjg.v9.i9.1959] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
2 Morris O, Elsawy MA, Fairclough M, Williams KJ, Mcmahon A, Grigg J, Forster D, Miller AF, Saiani A, Prenant C. In vivo characterisation of a therapeutically relevant self-assembling 18 F-labelled β-sheet forming peptide and its hydrogel using positron emission tomography. J Labelled Comp Radiopharm 2017;60:481-8. [PMID: 28623878 DOI: 10.1002/jlcr.3534] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
3 Tai YT, Lin YL, Chang CC, Cherng YG, Don MJ, Chen RM. Ring-oxidative biotransformation and drug interactions of propofol in the livers of rats. Biomed Res Int 2015;2015:658928. [PMID: 25710017 DOI: 10.1155/2015/658928] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]